AstraZeneca Infection Treatment Zavicefta Approved in EU
June 28 2016 - 2:42AM
Dow Jones News
By Rory Gallivan
LONDON--AstraZeneca PLC (AZN) on Tuesday announced that the
European Commission has approved the use of its infection treatment
Zavicefta.
The drug, which is used to treat urinary tract infections,
pneumonia and other conditions, can now be marketed in all 28
European Union countries as well as Iceland, Norway and
Liechtenstein, Astra said.
Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter:
@RoryGallivan
(END) Dow Jones Newswires
June 28, 2016 02:27 ET (06:27 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024
